Events

This is a Q&A Session for Industry about the recently published guidance on listed probiotic medicines.

Are you interested in applying to be a member of one of the TGA’s Statutory Advisory Committees? Hear first-hand from current members and the Chief Medical Adviser about what this exciting role is like.

Information session for external stakeholders about the proposed IVD regulation changes.

This webinar provides an overview of TGA’s Good Clinical Practice (GCP) Inspection Program clinical trial compliance activities.

An overview of the amended sponsor portal to include unapproved medical devices and provides guidance on how to apply for consent to import, supply or export medical devices that do not comply with the Essential Principles (EPs).

Guidance on completing updated notification form for new therapeutic vaping products, and information on the re-statement of compliance when requested by TGA.

See the upcoming changes in the PRAC – the new procedure document that will replace the Uniform Recalls Procedure for Therapeutic Goods (URPTG).

Presentations given by the TGA at the ARCS 2025 Regulatory Summit, 19 February 2025

Presentation given at the 2024 ACTA Symposium, in Melbourne

Presentations given by the TGA at the GMP Forum 19-20 November, Melbourne Convention and Exhibition Centre.

Changes to applicable product standards for unapproved therapeutic vaping goods in 2025

Hear about the options we currently considering in relation to the future regulation of assistive technologies. Q and A session included.

View the proposed changes to the post-market review compliance portal allowing sponsors of exempt devices to view and respond to regulatory notices, and ask questions and provide feedback on the proposed changes.

Therapeutic Goods Advertising Consultative Committee.

Webinar giving an overview of the software reclassification reforms and the transitional arrangements for software based medical devices affected by the changes.

View the proposed changes to the on-line application form for consent to import, export, or supply medical devices that do not comply with the Essential Principles.

This webinar provides information about the TGA’s public consultation paper on the proposed changes to the Australian Essential Principles and an opportunity to ask questions.

About the changes to the compounding of glucagon-like peptide-1 receptor agonist (GLP-1 RA) products and how these changes will impact pharmacists, doctors and consumers.

Webinar Tuesday 20 and Wednesday 21 August 2024

Presented at the ARCS Annual Conference 2024.

Presented at the ARCS Annual Conference 2024.

Presented at the ARCS Annual Conference 2024.

Presented at the ARCS Annual Conference 2024.

Presented at the ARCS Annual Conference 2024.

Presented at the ARCS Annual Conference 2024.